Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

[ANTIBIOTIC STEWARDSHIP IN ISRAEL - WHERE ARE WE HEADED IN 2018?]

Nesher L, Strahilevitz J.

Harefuah. 2019 May;158(5):321-326. Review. Hebrew.

PMID:
31104394
2.

Corrigendum to "association between the timing of surgery for complicated, left-sided infective endocarditis and survival", American HeartJournal 2019, volume 210, April 2019, pages 108-116.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Jun;212:165. doi: 10.1016/j.ahj.2019.03.006. Epub 2019 Apr 16. No abstract available.

PMID:
31003633
3.

The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis.

Fosbøl EL, Park LP, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE-PLUS Investigators.

Eur Heart J. 2019 Apr 12. pii: ehz204. doi: 10.1093/eurheartj/ehz204. [Epub ahead of print]

PMID:
30977784
4.

Association between the timing of surgery for complicated, left-sided infective endocarditis and survival.

Wang A, Chu VH, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Barsic B, Giannitsioti E, Hurley JP, Hannan MM, Park LP; ICE-PLUS Investigators.

Am Heart J. 2019 Apr;210:108-116. doi: 10.1016/j.ahj.2019.01.004. Epub 2019 Jan 17. Erratum in: Am Heart J. 2019 Jun;212:165.

PMID:
30802708
5.

Five years of fecal microbiota transplantation - an update of the Israeli experience.

Greenberg SA, Youngster I, Cohen NA, Livovsky DM, Strahilevitz J, Israeli E, Melzer E, Paz K, Fliss-Isakov N, Maharshak N.

World J Gastroenterol. 2018 Dec 21;24(47):5403-5414. doi: 10.3748/wjg.v24.i47.5403.

6.

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009-June 20151.

Regev-Yochay G, Reisenberg K, Katzir M, Wiener-Well Y, Rahav G, Strahilevitz J, Istomin V, Tsyba E, Peretz A, Khakshoor S, Dagan R; Israeli Adult Invasive Pneumococcal Disease Group.

Emerg Infect Dis. 2018 Jul;24(7):1275-1284. doi: 10.3201/eid2407.170721.

7.

Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.

Kleinhendler E, Cohen MJ, Moses AE, Paltiel O, Strahilevitz J, Cahan A.

Int J Antimicrob Agents. 2018 Jan;51(1):71-76. doi: 10.1016/j.ijantimicag.2017.06.016. Epub 2017 Jul 10.

PMID:
28705670
8.

The herd effects of infant PCV7/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel.

Regev-Yochay G, Katzir M, Strahilevitz J, Rahav G, Finn T, Miron D, Maor Y, Chazan B, Schindler Y, Dagan R; IAIPD group.

Vaccine. 2017 Apr 25;35(18):2449-2456. doi: 10.1016/j.vaccine.2017.03.031. Epub 2017 Mar 22.

PMID:
28342668
9.

Respiratory Viral Infections After Stem Cell Transplant.

Strahilevitz J, Shapira MY.

Clin Infect Dis. 2017 Feb 15;64(4):534. doi: 10.1093/cid/ciw812. No abstract available.

PMID:
28174910
10.

TDtest: easy detection of bacterial tolerance and persistence in clinical isolates by a modified disk-diffusion assay.

Gefen O, Chekol B, Strahilevitz J, Balaban NQ.

Sci Rep. 2017 Feb 1;7:41284. doi: 10.1038/srep41284.

11.

Response to Letter Regarding Article, "Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis: A Prospective Study From the International Collaboration on Endocarditis".

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; ICE Investigators.

Circulation. 2015 Oct 6;132(14):e184-5. doi: 10.1161/CIRCULATIONAHA.115.016782. No abstract available.

PMID:
26438777
12.

Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.

Tzadok R, Shapira MY, Moses AE, Or R, Block C, Strahilevitz J.

Mycoses. 2015 Dec;58(12):694-8. doi: 10.1111/myc.12416. Epub 2015 Oct 2.

PMID:
26429354
13.

A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia.

Gatt ME, Strahilevitz J, Sharon N, Lavie D, Goldschmidt N, Kalish Y, Gural A, Paltiel OB.

Integr Cancer Ther. 2015 Sep;14(5):428-35. doi: 10.1177/1534735415588928. Epub 2015 Jun 2.

PMID:
26036623
14.

Candida infective endocarditis: an observational cohort study with a focus on therapy.

Arnold CJ, Johnson M, Bayer AS, Bradley S, Giannitsioti E, Miró JM, Tornos P, Tattevin P, Strahilevitz J, Spelman D, Athan E, Nacinovich F, Fortes CQ, Lamas C, Barsic B, Fernández-Hidalgo N, Muñoz P, Chu VH.

Antimicrob Agents Chemother. 2015 Apr;59(4):2365-73. doi: 10.1128/AAC.04867-14. Epub 2015 Feb 2.

15.

Plasmid-mediated quinolone resistance.

Jacoby GA, Strahilevitz J, Hooper DC.

Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.PLAS-0006-2013. Review.

16.

Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.

Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, Miro JM, Mudrick DW, Strahilevitz J, Tribouilloy C, Durante-Mangoni E, Pericas JM, Fernández-Hidalgo N, Nacinovich F, Rizk H, Krajinovic V, Giannitsioti E, Hurley JP, Hannan MM, Wang A; International Collaboration on Endocarditis (ICE) Investigators*.

Circulation. 2015 Jan 13;131(2):131-40. doi: 10.1161/CIRCULATIONAHA.114.012461. Epub 2014 Dec 5.

PMID:
25480814
17.

Reply to "questionable utility of galactomannan testing for diagnosis of Exserohilum rostratum infection".

Korem M, Polacheck I, Strahilevitz J.

J Clin Microbiol. 2014 Jul;52(7):2744. doi: 10.1128/JCM.01164-14. No abstract available.

18.

Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey.

Korem M, Israel S, Gilon D, Cahan A, Moses AE, Block C, Strahilevitz J.

Eur J Intern Med. 2014 Jul;25(6):550-5. doi: 10.1016/j.ejim.2014.05.011. Epub 2014 Jun 12.

PMID:
24931808
19.

Visceral cat scratch disease with endocarditis in an immunocompetent adult: a case report and review of the literature.

Shasha D, Gilon D, Vernea F, Moses AE, Strahilevitz J.

Vector Borne Zoonotic Dis. 2014 Mar;14(3):175-81. doi: 10.1089/vbz.2012.1279. Epub 2014 Feb 27. Review.

PMID:
24575798
20.

Initial effects of the National PCV7 Childhood Immunization Program on adult invasive pneumococcal disease in Israel.

Regev-Yochay G, Rahav G, Riesenberg K, Wiener-Well Y, Strahilevitz J, Stein M, Glikman D, Weber G, Potasman I, Dagan R; IAIPD study group.

PLoS One. 2014 Feb 7;9(2):e88406. doi: 10.1371/journal.pone.0088406. eCollection 2014.

21.

Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study.

Alagna L, Park LP, Nicholson BP, Keiger AJ, Strahilevitz J, Morris A, Wray D, Gordon D, Delahaye F, Edathodu J, Miró JM, Fernández-Hidalgo N, Nacinovich FM, Shahid R, Woods CW, Joyce MJ, Sexton DJ, Chu VH.

Clin Microbiol Infect. 2014 Jun;20(6):566-75. doi: 10.1111/1469-0691.12395. Epub 2013 Nov 11.

22.

Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern community.

Banerjee R, Strahilevitz J, Johnson JR, Nagwekar PP, Schora DM, Shevrin I, Du H, Peterson LR, Robicsek A.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):947-53. doi: 10.1086/671725. Epub 2013 Jul 17.

23.

Galactomannan testing for early diagnosis of Exserohilum rostratum infection.

Korem M, Polacheck I, Michael-Gayego A, Strahilevitz J.

J Clin Microbiol. 2013 Aug;51(8):2800-1. doi: 10.1128/JCM.00955-13. Epub 2013 May 29. No abstract available.

24.

Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.

Averbuch D, Horwitz E, Strahilevitz J, Stepensky P, Goldschmidt N, Gatt ME, Shapira MY, Resnick IB, Engelhard D.

Infection. 2013 Oct;41(5):991-7. doi: 10.1007/s15010-013-0471-6. Epub 2013 May 8.

PMID:
23653428
25.

A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7.

Regev-Yochay G, Rahav G, Strahilevitz J, Bishara J, Katzir M, Chowers M, Finkelstein R, Chazan B, Zimhony O, Dagan R; IAIPD study group.

Vaccine. 2013 May 1;31(19):2387-94. doi: 10.1016/j.vaccine.2013.02.059. Epub 2013 Mar 19.

PMID:
23518404
26.

KPC-9, a novel carbapenemase from clinical specimens in Israel.

Hidalgo-Grass C, Warburg G, Temper V, Benenson S, Moses AE, Block C, Strahilevitz J.

Antimicrob Agents Chemother. 2012 Nov;56(11):6057-9. doi: 10.1128/AAC.01156-12. Epub 2012 Sep 10.

27.

Comparison of two carbapenem-resistant Klebsiella pneumoniae clones: from a contained outbreak in a paediatric population and from a national epidemic.

Benenson S, Warburg G, Hidalgo-Grass C, Temper V, Moses AE, Block C, Strahilevitz J.

J Antimicrob Chemother. 2012 Jul;67(7):1651-4. doi: 10.1093/jac/dks115. Epub 2012 Apr 11.

PMID:
22499995
28.

A carbapenem-resistant Klebsiella pneumoniae epidemic clone in Jerusalem: sequence type 512 carrying a plasmid encoding aac(6')-Ib.

Warburg G, Hidalgo-Grass C, Partridge SR, Tolmasky ME, Temper V, Moses AE, Block C, Strahilevitz J.

J Antimicrob Chemother. 2012 Apr;67(4):898-901. doi: 10.1093/jac/dkr552. Epub 2012 Jan 26.

PMID:
22287232
29.

The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.

Elad S, Epstein JB, Raber-Durlacher J, Donnelly P, Strahilevitz J.

J Oral Pathol Med. 2012 Mar;41(3):229-34. doi: 10.1111/j.1600-0714.2011.01094.x. Epub 2011 Nov 14.

PMID:
22077420
30.

High-resolution melt curve analysis for identification of single nucleotide mutations in the quinolone resistance gene aac(6')-Ib-cr.

Hidalgo-Grass C, Strahilevitz J.

Antimicrob Agents Chemother. 2010 Aug;54(8):3509-11. doi: 10.1128/AAC.00485-10. Epub 2010 May 24.

31.

Plasmid-mediated quinolone resistance: a multifaceted threat.

Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A.

Clin Microbiol Rev. 2009 Oct;22(4):664-89. doi: 10.1128/CMR.00016-09. Review.

32.

Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel.

Chmelnitsky I, Hermesh O, Navon-Venezia S, Strahilevitz J, Carmeli Y.

J Antimicrob Chemother. 2009 Oct;64(4):718-22. doi: 10.1093/jac/dkp272. Epub 2009 Aug 4.

PMID:
19656782
33.

Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.

Benenson S, Navon-Venezia S, Carmeli Y, Adler A, Strahilevitz J, Moses AE, Block C.

Int J Infect Dis. 2009 Sep;13(5):e295-8. doi: 10.1016/j.ijid.2009.01.006. Epub 2009 Mar 28.

34.

Changes in aac(6')-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of Escherichia coli collected from 1991 through 2005.

Warburg G, Korem M, Robicsek A, Engelstein D, Moses AE, Block C, Strahilevitz J.

Antimicrob Agents Chemother. 2009 Mar;53(3):1268-70. doi: 10.1128/AAC.01300-08. Epub 2008 Dec 22.

35.

Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin.

Strahilevitz J, Adler A, Smollan G, Temper V, Keller N, Block C.

Emerg Infect Dis. 2008 Oct;14(10):1667-9. doi: 10.3201/eid1410.080252. No abstract available.

36.

Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.

Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y.

Antimicrob Agents Chemother. 2008 Aug;52(8):2962-5. doi: 10.1128/AAC.01341-07. Epub 2008 Jun 2.

37.

Propionibacterium endocarditis: a case series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study.

Lalani T, Person AK, Hedayati SS, Moore L, Murdoch DR, Hoen B, Peterson G, Shahbaz H, Raoult D, Miro JM, Olaison L, Snygg-Martino U, Suter F, Spelman D, Eykyn S, Strahilevitz J, Van der Meer JT, Verhagen D, Baloch K, Abrutyn E, Cabell CH; International Collaboration on Endocarditis Merged; Database Study Group.

Scand J Infect Dis. 2007;39(10):840-8. Review.

PMID:
17852887
38.

Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005.

Strahilevitz J, Engelstein D, Adler A, Temper V, Moses AE, Block C, Robicsek A.

Antimicrob Agents Chemother. 2007 Aug;51(8):3001-3. Epub 2007 May 25.

39.

qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC.

Antimicrob Agents Chemother. 2006 Aug;50(8):2872-4.

40.

Phialemonium curvatum prosthetic valve endocarditis with an unusual echocardiographic presentation.

Osherov A, Schwammenthal E, Kuperstein R, Strahilevitz J, Feinberg MS.

Echocardiography. 2006 Jul;23(6):503-5.

PMID:
16839390
41.

Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica.

Gay K, Robicsek A, Strahilevitz J, Park CH, Jacoby G, Barrett TJ, Medalla F, Chiller TM, Hooper DC.

Clin Infect Dis. 2006 Aug 1;43(3):297-304. Epub 2006 Jun 20.

PMID:
16804843
42.

NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus.

Truong-Bolduc QC, Strahilevitz J, Hooper DC.

Antimicrob Agents Chemother. 2006 Mar;50(3):1104-7.

43.

Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.

Strahilevitz J, Robicsek A, Hooper DC.

Antimicrob Agents Chemother. 2006 Feb;50(2):600-6.

44.

Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.

Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, Bush K, Hooper DC.

Nat Med. 2006 Jan;12(1):83-8. Epub 2005 Dec 20.

PMID:
16369542
45.

Case clustering in infective endocarditis: the role of availability bias.

Strahilevitz J, Zellermayer O, Vangel MG, Yonath H, Feinberg MS, Rubinstein E.

Clin Microbiol Infect. 2005 Dec;11(12):955-7.

47.

An improved expression plasmid for affinity purification of Staphylococcus aureus gyrase A subunit.

Strahilevitz J, Onodera Y, Hooper DC.

Protein Expr Purif. 2006 May;47(1):10-5. Epub 2005 Sep 21.

PMID:
16289915
48.

A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.

de Souza NJ, Gupte SV, Deshpande PK, Desai VN, Bhawsar SB, Yeole RD, Shukla MC, Strahilevitz J, Hooper DC, Bozdogan B, Appelbaum PC, Jacobs MR, Shetty N, Patel MV, Jha R, Khorakiwala HF.

J Med Chem. 2005 Aug 11;48(16):5232-42.

PMID:
16078842
49.

Broader distribution of plasmid-mediated quinolone resistance in the United States.

Robicsek A, Sahm DF, Strahilevitz J, Jacoby GA, Hooper DC.

Antimicrob Agents Chemother. 2005 Jul;49(7):3001-3.

Supplemental Content

Loading ...
Support Center